The Isabel Feld Myeloma Research Fund
The Isabel Feld Myeloma Research Fund was started by Isabel’s daughter, Stephanie Feld, in Isabel’s memory. Isabel became ill in 1997 and was seen by two different hematologists who misdiagnosed her, underlining the importance of patient advocacy and of seeking a second opinion.
Isabel succumbed to the disease very quickly and Stephanie was compelled to do something so other patients would have better outcomes. The fund’s mission is to support the MMRF—to accelerate drug discovery and drive new, more effective treatments to patients.